Personalized Cancer Medicine Market Size, Share, Trends, Growth 2034

Personalized Cancer Medicine Market

Personalized Cancer Medicine Market By Type (Personalized Medicine Diagnostics and Personalized Medicine Therapeutics), By End-User (Clinics, Hospitals, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Healthcare Report Format : PDF Pages: 227 Report Code: ZMR-10609 Published Date: May-2026 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 95.23 Billion USD 279.87 Billion 12.51% 2024

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Personalized Cancer Medicine Market, (2025 - 2034) (USD Billion)
    • 2.2 Global Personalized Cancer Medicine Market : snapshot
  • Chapter 3. Global Personalized Cancer Medicine Market - Industry Analysis
    • 3.1 Personalized Cancer Medicine Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Shift toward targeted approach and immunotherapy to work in favor of the industry players
    • 3.3 Market Restraints
      • 3.3.1. Cost barriers limit the expansion of the personalized cancer medicine market
    • 3.4 Market Opportunities
      • 3.4.1. Use of Artificial Intelligence (AI) in personalized cancer medicine to offer new growth opportunities
    • 3.5 Market Challenges
      • 3.5.1. Lack of infrastructure and a skilled workforce to challenge market growth over the forecast period
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Type
      • 3.7.2 Market attractiveness analysis By End-User
  • Chapter 4. Global Personalized Cancer Medicine Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Personalized Cancer Medicine Market: company market share, 2024
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Personalized Cancer Medicine Market - Type Analysis
    • 5.1 Global Personalized Cancer Medicine Market overview: By Type
      • 5.1.1 Global Personalized Cancer Medicine Market share, By Type, 2024 and 2034
    • 5.2 Personalized Medicine Diagnostics
      • 5.2.1 Global Personalized Cancer Medicine Market by Personalized Medicine Diagnostics, 2025 - 2034 (USD Billion)
    • 5.3 Personalized Medicine Therapeutics
      • 5.3.1 Global Personalized Cancer Medicine Market by Personalized Medicine Therapeutics, 2025 - 2034 (USD Billion)
  • Chapter 6. Global Personalized Cancer Medicine Market - End-User Analysis
    • 6.1 Global Personalized Cancer Medicine Market overview: By End-User
      • 6.1.1 Global Personalized Cancer Medicine Market share, By End-User, 2024 and 2034
    • 6.2 Clinics
      • 6.2.1 Global Personalized Cancer Medicine Market by Clinics, 2025 - 2034 (USD Billion)
    • 6.3 Hospitals
      • 6.3.1 Global Personalized Cancer Medicine Market by Hospitals, 2025 - 2034 (USD Billion)
    • 6.4 Others
      • 6.4.1 Global Personalized Cancer Medicine Market by Others, 2025 - 2034 (USD Billion)
  • Chapter 7. Personalized Cancer Medicine Market - Regional Analysis
    • 7.1 Global Personalized Cancer Medicine Market Regional Overview
    • 7.2 Global Personalized Cancer Medicine Market Share, by Region, 2024 & 2034 (USD Billion)
    • 7.3. North America
      • 7.3.1 North America Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
        • 7.3.1.1 North America Personalized Cancer Medicine Market, by Country, 2025 - 2034 (USD Billion)
    • 7.4 North America Personalized Cancer Medicine Market, by Type, 2025 - 2034
      • 7.4.1 North America Personalized Cancer Medicine Market, by Type, 2025 - 2034 (USD Billion)
    • 7.5 North America Personalized Cancer Medicine Market, by End-User, 2025 - 2034
      • 7.5.1 North America Personalized Cancer Medicine Market, by End-User, 2025 - 2034 (USD Billion)
    • 7.4. Europe
      • 7.4.2 Europe Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
        • 7.4.2.1 Europe Personalized Cancer Medicine Market, by Country, 2025 - 2034 (USD Billion)
    • 7.4 Europe Personalized Cancer Medicine Market, by Type, 2025 - 2034
      • 7.4.1 Europe Personalized Cancer Medicine Market, by Type, 2025 - 2034 (USD Billion)
    • 7.5 Europe Personalized Cancer Medicine Market, by End-User, 2025 - 2034
      • 7.5.1 Europe Personalized Cancer Medicine Market, by End-User, 2025 - 2034 (USD Billion)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
        • 7.5.3.1 Asia Pacific Personalized Cancer Medicine Market, by Country, 2025 - 2034 (USD Billion)
    • 7.4 Asia Pacific Personalized Cancer Medicine Market, by Type, 2025 - 2034
      • 7.4.1 Asia Pacific Personalized Cancer Medicine Market, by Type, 2025 - 2034 (USD Billion)
    • 7.5 Asia Pacific Personalized Cancer Medicine Market, by End-User, 2025 - 2034
      • 7.5.1 Asia Pacific Personalized Cancer Medicine Market, by End-User, 2025 - 2034 (USD Billion)
    • 7.6. Latin America
      • 7.6.4 Latin America Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
        • 7.6.4.1 Latin America Personalized Cancer Medicine Market, by Country, 2025 - 2034 (USD Billion)
    • 7.4 Latin America Personalized Cancer Medicine Market, by Type, 2025 - 2034
      • 7.4.1 Latin America Personalized Cancer Medicine Market, by Type, 2025 - 2034 (USD Billion)
    • 7.5 Latin America Personalized Cancer Medicine Market, by End-User, 2025 - 2034
      • 7.5.1 Latin America Personalized Cancer Medicine Market, by End-User, 2025 - 2034 (USD Billion)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
        • 7.7.5.1 The Middle-East and Africa Personalized Cancer Medicine Market, by Country, 2025 - 2034 (USD Billion)
    • 7.4 The Middle-East and Africa Personalized Cancer Medicine Market, by Type, 2025 - 2034
      • 7.4.1 The Middle-East and Africa Personalized Cancer Medicine Market, by Type, 2025 - 2034 (USD Billion)
    • 7.5 The Middle-East and Africa Personalized Cancer Medicine Market, by End-User, 2025 - 2034
      • 7.5.1 The Middle-East and Africa Personalized Cancer Medicine Market, by End-User, 2025 - 2034 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1 AstraZeneca
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Novartis
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Bristol Myers Squibb
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Illumina
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Guardant Health
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Caris Life Sciences
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 NeoGenomics Laboratories
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Roche
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Foundation Medicine
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Pfizer
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
    • 8.11 Tempus
      • 8.11.1 Overview
      • 8.11.2 Financials
      • 8.11.3 Product Portfolio
      • 8.11.4 Business Strategy
      • 8.11.5 Recent Developments
    • 8.12 GRAIL
      • 8.12.1 Overview
      • 8.12.2 Financials
      • 8.12.3 Product Portfolio
      • 8.12.4 Business Strategy
      • 8.12.5 Recent Developments
    • 8.13 Johnson & Johnson
      • 8.13.1 Overview
      • 8.13.2 Financials
      • 8.13.3 Product Portfolio
      • 8.13.4 Business Strategy
      • 8.13.5 Recent Developments
    • 8.14 Merck & Co.
      • 8.14.1 Overview
      • 8.14.2 Financials
      • 8.14.3 Product Portfolio
      • 8.14.4 Business Strategy
      • 8.14.5 Recent Developments
    • 8.15 Exact Sciences
      • 8.15.1 Overview
      • 8.15.2 Financials
      • 8.15.3 Product Portfolio
      • 8.15.4 Business Strategy
      • 8.15.5 Recent Developments
    • 8.16 and others.
      • 8.16.1 Overview
      • 8.16.2 Financials
      • 8.16.3 Product Portfolio
      • 8.16.4 Business Strategy
      • 8.16.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Personalized Cancer Medicine Market attractiveness, By Type
  • 6. Global Personalized Cancer Medicine Market attractiveness, By End-User
  • 7. Global Personalized Cancer Medicine Market share by Type, 2025 and 2034 (USD Billion)
  • 8. Global Personalized Cancer Medicine Market by Personalized Medicine Diagnostics, 2025 - 2034 (USD Billion)
  • 9. Global Personalized Cancer Medicine Market by Personalized Medicine Therapeutics, 2025 - 2034 (USD Billion)
  • 10. Global Personalized Cancer Medicine Market share by End-User, 2025 and 2034 (USD Billion)
  • 11. Global Personalized Cancer Medicine Market by Clinics, 2025 - 2034 (USD Billion)
  • 12. Global Personalized Cancer Medicine Market by Hospitals, 2025 - 2034 (USD Billion)
  • 13. Global Personalized Cancer Medicine Market by Others, 2025 - 2034 (USD Billion)
  • 14. Global Personalized Cancer Medicine Market share, by Region, 2025 and 2034
  • 15. North America Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
  • 16. Europe Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
  • 17. Asia Pacific Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
  • 18. Latin America Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)
  • 19. The Middle-East and Africa Personalized Cancer Medicine Market, 2025 - 2034 (USD Billion)

Table Of Tables

  • 1. Global Personalized Cancer Medicine Market: Snapshot
  • 2. Drivers of the Personalized Cancer Medicine Market: impact analysis
  • 3. North America Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 4. North America Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 5. U.S. Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 6. U.S. Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 7. Canada Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 8. Canada Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 9. Europe Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 10. Europe Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 11. Germany Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 12. Germany Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 13. France Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 14. France Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 15. U.K. Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 16. U.K. Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 17. Italy Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 18. Italy Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 19. Spain Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 20. Spain Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 21. Rest of Europe Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 22. Rest of Europe Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 23. Asia Pacific Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 24. Asia Pacific Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 25. China Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 26. China Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 27. Japan Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 28. Japan Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 29. India Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 30. India Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 31. South Korea Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 32. South Korea Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 33. South-East Asia Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 34. South-East Asia Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 35. Rest of Asia Pacific Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 36. Rest of Asia Pacific Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 37. Latin America Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 38. Latin America Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 39. Brazil Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 40. Brazil Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 41. Mexico Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 42. Mexico Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 43. Rest of Latin America Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 44. Rest of Latin America Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 45. The Middle-East and Africa Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 46. The Middle-East and Africa Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 47. GCC Countries Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 48. GCC Countries Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 49. South Africa Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 50. South Africa Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)
  • 51. Rest of Middle-East Africa Personalized Cancer Medicine Market revenue, By Type, 2025 - 2034 (USD Billion)
  • 52. Rest of Middle-East Africa Personalized Cancer Medicine Market revenue, By End-User, 2025 - 2034 (USD Billion)

Methodology

FrequentlyAsked Questions

Personalized cancer medicine is a customized approach toward detecting, treating, and managing cancer.

The global personalized cancer medicine market is expected to be driven by the growing prevalence of cancer worldwide.

According to study, the global personalized cancer medicine market size was worth around USD 95.23 billion in 2024 and is predicted to grow to around USD 279.87 billion by 2034.

The CAGR value of the personalized cancer medicine market is expected to be around 12.51% during 2025-2034.

The global personalized cancer medicine industry is expected to be challenged by the lack of supportive infrastructure and skilled workforce.

Advancements in cell and gene therapies and focus on early detection are the emerging trends and innovations impacting the personalized cancer medicine market.

The global personalized cancer medicine market has performed well so far and will offer similar trends in the coming years.

Asia-Pacific will contribute notably towards the personalized cancer medicine market value.

The global personalized cancer medicine market is led by players like AstraZeneca, Novartis, Bristol Myers Squibb, Illumina, Guardant Health, Caris Life Sciences, NeoGenomics Laboratories, Roche, Foundation Medicine, Pfizer, Tempus, GRAIL, Johnson & Johnson, Merck & Co., and  Exact Sciences.

The report explores crucial aspects of the personalized cancer medicine market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

Personalized Cancer MedicineIndustry Perspective:Key Insights:OverviewDynamicsReport ScopeSegmentationRegional AnalysisCompetitive AnalysisWhat are the latest key trends in the personalized cancer medicine market?The global personalized cancer medicine market is segmented as follows:

HappyClients